      |
|
|
|
|
|
Our
Business - In 1976, Merck & Co. Inc established it's operation at Ballydine, near Clonmel in Co. Tipperary, where it now employs more than 350 people. It is a large-scale plant producing active pharmaceutical ingredients for use in pharmaceutical manufacturing by Merck & Co., Inc. subsidiaries throughout the world. Recently the site moved into the development of late stage clinical API. This involves laboratory scale process development followed by plant scale up to both pilot plant and full scale production, as well as preparation for regulatory filings. In September 2007, construction will start on a Formulation R&D and Manufacturing Facility located on the existing site. This €100 million investment will support Merck's commercialisation initiative that will bring new medicines to market more quickly and flexibly and will significantly increase the overall level of research and development conducted at the site. The Formulation R&D centre will develop innovative platforms for the formulation of products used in late stage clinical trials while the Formulation Manufacturing facility will enable the plant to produce tablets and capsules for a number of new products in late stage clinical trials and for new products launched on the market. It is anticipated that 120 new positions will be created over the next three years, including approximately 60 R&D positions. |
|
|